Cencora is a global pharmaceutical solutions organization that evolved from AmerisourceBergen, dedicated to enhancing the lives of both people and animals. The company connects pharmaceutical partners, healthcare providers, and patients to ensure timely access to necessary therapies. Cencora consolidates the services of AmerisourceBergen while focusing on its core pharmaceutical distribution business and expanding its platform of services to support pharmaceutical innovation and access. With a workforce of over 46,000 employees, Cencora plays a significant role in the healthcare sector, handling a substantial portion of pharmaceuticals distributed in the U.S. The company is committed to streamlining healthcare costs through efficient operations and robust supply chain management, ensuring the safety and security of the pharmaceutical supply chain. Additionally, Cencora provides business support and consulting services to allow healthcare providers to focus on patient care, while also offering specialized distribution services for various medical fields, including oncology, immunology, and pediatrics. Headquartered in Valley Forge, Pennsylvania, Cencora represents a unified brand with a strong international presence.
Retina Consultants of America is a network of retinal practices dedicated to providing comprehensive retinal care. The organization employs a physician-centered practice management model that empowers retinal specialists to deliver high-quality surgical and clinical services. By focusing on innovative treatments and supporting clinical decision-making, Retina Consultants enhances patient experiences and outcomes. The company aims to save sight and improve the lives of patients through its commitment to advancing retinal health and providing complete healthcare services.
Sempre Health
Venture Round in 2023
Sempre Health, Inc. operates a behavior-based healthcare pricing platform that collaborates with health plans and pharmaceutical manufacturers to offer dynamic co-payment adjustments based on individual patient adherence and behavior. Founded in 2015 and based in San Francisco, the company analyzes prescription records to forecast the most appropriate price for medications based on a patient's timely adherence. Patients receive personalized SMS messages that inform them of potential discounts and encourage prompt prescription refills, such as alerts indicating that filling a prescription today may cost $10, while delaying could raise the price to $30. This innovative approach not only aims to improve patients' access to affordable care but also generates valuable real-world data on patient price sensitivities and cost behaviors.
SteadyMD
Venture Round in 2023
SteadyMD, Inc. is a provider of online primary care services based in St. Louis, Missouri, with an additional office in Westlake Village, California. Founded in 2016, the company connects patients with board-certified clinicians through a digital platform that facilitates telehealth services for various medical conditions, dietary preferences, and lifestyle choices. Patients can communicate with their doctors via text, call, or video chat, allowing for personalized and comprehensive care. SteadyMD also serves as a telehealth infrastructure provider, enabling healthcare leaders to scale their telehealth offerings across all 50 states by providing a licensed clinician workforce and support in clinical operations, legal, and regulatory matters. The company's innovative approach aims to improve access to high-quality care by addressing the complexities of chronic illnesses and ensuring that patients receive adequate time and attention from their healthcare providers.
OneOncology
Secondary Market in 2023
OneOncology, Inc. is a partnership of independent oncologists and industry experts focused on transforming community-based cancer care in the United States. Founded in 2007 and headquartered in Orlando, Florida, the company operates a network that supports independent oncology practices by providing essential resources and technologies. OneOncology offers AssistPoint, an enterprise workflow platform designed to streamline the administrative aspects of patient care. Additionally, it serves as an electronic distribution channel for pharmaceuticals, facilitating connections among manufacturers, physicians, distributors, and payers. Through strategic partnerships, OneOncology empowers oncologists to enhance their practices, share knowledge, and innovate in cancer care delivery, ensuring comprehensive support for patients and their families in their local communities.
WhizAI
Series A in 2022
WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies. Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more. WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation.
PharmaLex
Acquisition in 2022
PharmaLex is a specialized service provider for the pharmaceutical, biotechnology, and medical device industries. The company assists clients throughout the entire product lifecycle, from early strategic planning and non-clinical requirements to clinical development, regulatory submissions, and post-launch maintenance activities. By leveraging technology-enabled solutions, PharmaLex helps companies navigate the complex regulatory landscape associated with drug and medical device approval, ensuring compliance and facilitating a quicker time to market. With a workforce of over 3,000 employees and 67 offices across 32 countries, PharmaLex serves a diverse client base, including developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies, vaccines, and biosimilars. The firm is committed to delivering customized solutions that exceed standard practices and meet the unique needs of its clients worldwide.
WhizAI
Series A in 2021
WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies. Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more. WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation.
TrakCel
Corporate Round in 2021
TrakCel Ltd. is a technology company that provides a comprehensive suite of integrated solutions for managing the cell therapy supply chain, catering to both autologous and allogeneic therapies. Founded in 2012 and headquartered in Cardiff, United Kingdom, TrakCel offers a cloud-based Cell Orchestration Platform that enhances the efficiency of cell and gene therapy development. This platform enables users to collate, track, and document critical information throughout various stages of therapy programs, facilitating compliance with regulatory audits. The company serves a diverse clientele, including medical centers, logistics providers, manufacturers, and therapy developers, and collaborates with both commercial and academic organizations focused on improving human health. By replacing outdated paper-based systems, TrakCel's technology helps streamline data management, reporting, and analysis needs in clinical trials, ultimately reducing time, costs, and risks associated with therapy development.
H. D. Smith
Acquisition in 2017
H. D. Smith, LLC is a prominent distributor of healthcare products and business solutions in the United States, serving manufacturers and healthcare providers since its founding in 1954. Headquartered in Springfield, Illinois, the company operates distribution centers across several states, including California, Florida, Kentucky, and Texas. H. D. Smith supplies a wide range of products, including prescription and over-the-counter pharmaceuticals, home healthcare supplies, durable medical equipment, and pharmacy supplies. Its customer base includes retail pharmacies, alternate care facilities, and various institutions. In January 2018, H. D. Smith became a subsidiary of AmerisourceBergen Corporation, further enhancing its ability to deliver essential healthcare solutions nationwide.
St. Francis Group
Acquisition in 2016
St. Francis Group is the largest animal health buying group in the United Kingdom. The organization provides a range of information and support services for veterinary products and animal health. By offering its members access to valuable information, technology, and administrative support, St. Francis Group aims to simplify their operational processes and enhance purchasing advantages. This approach allows its members to concentrate more on delivering clinical care, thereby improving the overall quality of veterinary services.
PharMEDium Healthcare
Acquisition in 2015
PharMEDium Healthcare specializes in customized sterile compounding for hospital intravenous and epidural therapies. Founded in 2003 and headquartered in Lake Forest, Illinois, the company offers a range of compounding services, including formulations for Calcium Chloride, Esmolol, Fentanyl, and Methadone, among others. PharMEDium Healthcare also provides outsourced hospital pharmacy services, focusing on sterile admixture, pain management, nerve block, and anesthesia solutions. In October 2015, the company was acquired by AmerisourceBergen Corporation.
MWI Veterinary Supply
Acquisition in 2015
MWI Veterinary Supply, founded in 1976 by Millard Wallace Ickes, DVM, in Nampa, Idaho, specializes in providing a wide range of animal health products to veterinarians. Initially established to meet the needs of professionals in the Northwest, MWI has expanded its offerings to include pharmaceuticals, vaccines, dental and diagnostic supplies, veterinary pet food, grooming products, surgical equipment, X-ray machines, and nutritional items. The company's commitment to quality service and competitive pricing has fueled its growth, enabling it to serve customers across the United States effectively. MWI focuses on developing solutions that support the success of veterinary practices, ensuring both their own growth and that of their clients.
Profarma
Post in 2014
Profarma has been engaged for 52 years in the distribution of pharmaceuticals, personal care products and cosmetics. The company provides medicines, personal care, health and beauty care, oncological, and dermatological products; and toiletries, vaccines, prostheses, and hormones in the South, Southeast, Northeast, and Center-West regions of Brazil.
World Courier
Acquisition in 2012
World Courier is a logistics service provider specializing in the transportation and storage of time- and temperature-sensitive healthcare products for pharmaceutical companies. The company focuses on understanding the strategic business objectives of its clients to design and execute logistics processes that enhance the efficiency of their operations. With a strong emphasis on mitigating risks and maximizing returns on research and development investments, World Courier ensures the optimal handling, transport, and delivery of vital medicines. Its experienced personnel and global network of offices enable the company to offer tailored solutions that prioritize safety and cost-effectiveness in the logistics of healthcare products.
IntrinsiQ
Acquisition in 2011
IntrinsiQ specializes in oncology information and software solutions that enhance cancer care quality and understanding. Their primary product, IntelliDose, is a clinical software tool that supports oncology professionals by managing chemotherapy treatments and workflows. This system reduces manual errors, enhances patient care, and increases operational efficiency within medical practices. By collecting and analyzing treatment data, IntelliDose provides valuable insights into oncologists' treatment strategies, the effectiveness of various therapies, and potential areas for improvement in patient care. These insights benefit not only oncologists and hospitals but also pharmaceutical companies, aiding in the optimization of services, operations, clinical trials, and drug development.
Bellco Health
Acquisition in 2007
Bellco Health is a privately held distributor specializing in both branded and generic pharmaceuticals. The company primarily markets and sells generic pharmaceuticals to individual retail pharmacies, ensuring they have access to a wide range of medications. Additionally, Bellco Health provides pharmaceutical products and services specifically tailored for dialysis clinics, catering to the unique needs of patients undergoing treatment. Through its focused distribution network, the company plays a crucial role in delivering essential medications to various healthcare providers.
Xcenda
Acquisition in 2007
Xcenda is a healthcare consulting firm based in Conshohocken, Pennsylvania, specializing in strategic insights and support for market access. The company provides a range of services, including health economics and outcomes research, reimbursement assistance, health policy analysis, and market research. Xcenda serves both established global companies and emerging firms in the pre-commercialization phase, helping clients navigate the complexities of the healthcare landscape and improve their market positioning. Through its expertise, Xcenda aims to deliver quality consulting services that enhance clients' understanding of market dynamics and facilitate successful product access and reimbursement strategies.
Access M.D.
Acquisition in 2006
AMD is a Canadian company providing services, including reimbursement support programs, third-party logistics and nursing support services, to manufacturers of specialty pharmaceuticals, such as injectable and biological therapies.
IgG America
Acquisition in 2006
IgG America is the specialty infusion pharmacy dedicated exclusively to providing immunoglobulin therapy. As an accredited specialty pharmacy, we have national reach and a legacy of care that spans thousands of patients.
PMSI
Acquisition in 2006
PMSI provides Medicare set-aside cost containment services to insurance payers, primarily within the workers' compensation industry. It offers PharmaComplete solution, which addresses the retail pharmacy lifecycle by providing prescription dispensing; and DMEComplete solution that integrates network penetration strategies with clinical utilization controls to control costs, simplify claims management, and support optimal health outcomes for injured workers.
Brecon Pharmaceuticals
Acquisition in 2006
Brecon Pharmaceuticals is a privately held provider of contract packaging and clinical trial materials services for pharmaceutical manufacturers. Brecon Pharmaceuticals is one of the contract packaging and CTM companies in the United Kingdom, providing packaging services for pharmaceuticals intended for sale by pharmaceutical manufacturers throughout Europe and Asia.
Network for Medical Communications & Research
Acquisition in 2006
Network for Medical Communications & Research a privately held provider of physician accredited continuing medical education and analytical research for the oncology market.
Trent Drug
Acquisition in 2005
Trent Drug is a privately held company and one of the national pharmaceutical distributors in Canadain, categorized under Drugs, Proprietaries, and Sundries.
Anderson Packaging
Acquisition in 2003
Anderson Packaging is a privately held contract pharmaceutical packaging company providing physician samples and retail contract packaging services to pharmaceutical manufacturers.
US Bioservices
Acquisition in 2003
US Bioservices is an independent specialty pharmacy based in Frisco, Texas, that has been providing trusted patient support solutions for over 20 years. Founded in 1994 by Ethan Leder and Mark Clein, the company offers a range of services aimed at facilitating communication between healthcare providers and pharmacies. One of its key offerings is the MyPathpoint Portal, which enhances transparency in pharmacy operations and clinical records. In January 2003, US Bioservices was acquired by AmerisourceBergen Corporation, further integrating its services within a larger healthcare framework.
Bridge Medical
Acquisition in 2003
Bridge Medical is the leading provider of barcode-enabled point-of-care (BPOC) software designed to reduce medication errors and decrease costs in healthcare facilities.
AutoMed Technologies
Acquisition in 2002
AutoMed Technologies is a provider of automated pharmacy dispensing equipment. AutoMed is uniquely positioned in the pharmacy automation marketplace. Combining software, equipment and workflow design, AutoMed has the only truly integrated pharmacy automation solution.
Pharmacy Healthcare Solutions
Acquisition in 2000
Pharmacy Healthcare Solutions is a pharmacy consulting firm that focuses on acute-care hospitals and healthcare systems. The company provides a range of services aimed at enhancing patient care and operational efficiency. These services include strategic consulting on medication processes and policies, medication tracking, coordinated patient care, and chronic disease management. Additionally, Pharmacy Healthcare Solutions offers support in supply chain management, pharmacy inventory management, and insourcing services. By implementing solutions like ambulatory pharmacy services and discharge prescription concierge services, the company helps healthcare providers reduce prescription costs and improve care continuity after patient discharge. Through its comprehensive approach, Pharmacy Healthcare Solutions aims to facilitate better health outcomes and operational success for its clients.
CD Smith Healthcare
Acquisition in 1999
CD Smith Healthcare is a full-service regional pharmaceutical distributor in the U.S. and has one of the strongest market shares among all distributors in its core Midwestern U.S. territory.
Lash Group
Acquisition in 1998
Lash Group is a healthcare consulting firm. Lash Group applies highly trained personnel and a customer service philosophy of putting the patient first.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.